Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

Literature DB >> 11864905

Macular infarction after intravitreal amikacin: mounting evidence against amikacin.

G Galloway, A Ramsay, K Jordan, A Vivian.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 11864905 PMCID： PMC1771055 DOI： 10.1136/bjo.86.3.359

Source DB: PubMed Journal: Br J Ophthalmol ISSN： 0007-1161 Impact factor: 4.638

× No keyword cloud information.

11 in total

1. Amikacin retinal toxicity.

Authors: T L Jackson; T H Williamson
Journal: Br J Ophthalmol Date: 1999-10 Impact factor: 4.638

2. Successful treatment of gram-negative endophthalmitis with intravitreous ceftazidime.

Authors: J I Lim; P A Campochiaro
Journal: Arch Ophthalmol Date: 1992-12

3. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study.

Authors: D P Han; S R Wisniewski; L A Wilson; M Barza; A K Vine; B H Doft; S F Kelsey
Journal: Am J Ophthalmol Date: 1996-07 Impact factor: 5.258

4. Preretinal haemorrhages: an unusual manifestation of intravitreal amikacin toxicity.

Authors: A Kumar; T Dada
Journal: Aust N Z J Ophthalmol Date: 1999-12

5. Macula toxicity after intravitreal amikacin.

Authors: A A Seawright; R D Bourke; R J Cooling
Journal: Aust N Z J Ophthalmol Date: 1996-05

6. Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.

Authors: P A Campochiaro; B P Conway
Journal: Arch Ophthalmol Date: 1991-07

7. Empiric treatment of endophthalmitis. Are aminoglycosides necessary?

Authors: S P Donahue; R P Kowalski; A W Eller; J M DeVaro; B H Jewart
Journal: Arch Ophthalmol Date: 1994-01

8. Toxicity of intravitreous ceftazidime in primate retina.

Authors: P A Campochiaro; W R Green
Journal: Arch Ophthalmol Date: 1992-11

9. Endophthalmitis caused by gram-negative organisms.

Authors: W D Irvine; H W Flynn; D Miller; S C Pflugfelder
Journal: Arch Ophthalmol Date: 1992-10

10. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group.

Authors:
Journal: Arch Ophthalmol Date: 1995-12

19 in total

1. Macular infarction after intravitreal amikacin.

Authors: B H Doft; M Barza
Journal: Br J Ophthalmol Date: 2004-06 Impact factor: 4.638

2. Macular infarction after intravitreal amikacin: authors' reply.

Authors: G D Galloway; A Ramsay; K Jordan; A Vivian
Journal: Br J Ophthalmol Date: 2004-09 Impact factor: 4.638

3. Ciprofloxacin in endophthalmitis: an alternative to ceftazidime and amikacin!

Authors: V Vedantham
Journal: Br J Ophthalmol Date: 2005-02 Impact factor: 4.638

4. [Rational antibiotic therapy in ophthalmology].

Authors: W Behrens-Baumann; U Frank; T Ness
Journal: Ophthalmologe Date: 2010-04 Impact factor: 1.059

5. Optical coherence tomography and fundus fluorescein angiography of a case of macular toxicity from intravitreal amikacin.

Authors: Damien Chia Ming Yeo; Dongying Zhao; Matthew Smith; Ayad Al-bermani
Journal: BMJ Case Rep Date: 2016-02-26

Review 6. Evidence for and against intravitreous corticosteroids in addition to intravitreous antibiotics for acute endophthalmitis.

Authors: Diem K Bui; Petros E Carvounis
Journal: Int Ophthalmol Clin Date: 2014

7. [Prophylaxis and therapy of postoperative endophthalmitis. Criticism of the ESCRS study and the Early Vitrectomy study].

Authors: W Behrens-Baumann
Journal: Ophthalmologe Date: 2011-11 Impact factor: 1.059